Broad-spectrum suppression of bacterial pneumonia by aminoglycoside-propagated Acinetobacter baumannii
نویسندگان
چکیده
منابع مشابه
Ventilator Associated Pneumonia by Acinetobacter baumannii And antimicrobial susceptibility pattern
Background: Ventilator Associated Pneumonia (VAP) is one of the serious complications of ventilator support occurring in ICUs. The aim of this study was to determine the susceptibility pattern of Acinetobacter baumannii (A. baumannii) isolated from patients with VAP by two methods: disk diffusion and E. test. Methods: This descriptive-cross sectional study was conducted in the four ICUs of Ras...
متن کاملCommunity-acquired pneumonia infections by Acinetobacter baumannii
In this issue of Virulence, Asplund et al., provides a proof of principle study indicating that physiological concentrations of alcohol impair macrophage antimicrobial functions against Acinetobacter baumannii (Ab). Thus, this communication delivers seminal evidence that alcohol and macrophages plays a key role the pathogenesis of Ab. Ab is a wide spectrum of intrinsic and acquired multidrug-re...
متن کاملPrevalence of Aminoglycoside Resistance Genes in Acinetobacter baumannii Isolates
BACKGROUND Acinetobacter baumannii is one of the major causes of nosocomial infections and is resistant to most available antibiotics. Aminoglycosides remain as drugs of choice for treatment of Acinetobacter infections yet resistance to aminoglycosides has increased in the recent years. OBJECTIVES The present study investigated the prevalence of genes encoding aminoglycoside-modifying enzymes...
متن کاملVerdamicin, a new broad spectrum aminoglycoside antibiotic.
Verdamicin is a new aminoglycoside antibiotic isolated from fermentation broths of a species of the genus Micromonospora, M. grisea. It has been differentiated from other known related antibiotics by a variety of chemical and biological methods. Its in vitro and in vivo spectrum of activity appears to be similar to those of gentamicin and sisomicin.
متن کاملPotent in vitro antibacterial activity of DS-8587, a novel broad-spectrum quinolone, against Acinetobacter baumannii.
We investigated the in vitro activity of DS-8587, a novel fluoroquinolone, against Acinetobacter baumannii. The MICs of DS-8587 against clinical isolates and its inhibitory activity against target enzymes were superior to those of ciprofloxacin and levofloxacin. Furthermore, the antibacterial activity of DS-8587 was less affected by adeA/adeB/adeC or abeM efflux pumps than was that of ciproflox...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLOS Pathogens
سال: 2020
ISSN: 1553-7374
DOI: 10.1371/journal.ppat.1008374